Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with fatty liver disease confirmed by a tissue sample (biopsy)
- You have been diagnosed with fatty liver disease confirmed by a scan or imaging test (such as an ultrasound or MRI)
Who may not be able to join:
- You have a history of drinking significant amounts of alcohol
- You have a viral liver infection, such as hepatitis B or hepatitis C
- You have a condition where your immune system attacks your liver (autoimmune hepatitis)
- You have certain inherited or metabolic conditions that affect the liver, such as hemochromatosis, Wilson's disease, or alpha-1 antitrypsin deficiency
- You take certain medications that can be harmful to the liver, such as amiodarone (confirm with trial site for other medications that may apply)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Won Kim, Professor, SMG-SNU Boramae Medical Center
Phone: 8228702233
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
histologic steatosis and fibrosis grade
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.